| 000 | 01919 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515011946.0 | ||
| 264 | 0 | _c20060209 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2005.02.1717 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBernstein, Mark L | |
| 245 | 0 | 0 |
_aIntensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cJan 2006 |
||
| 300 |
_a152-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmifostine _xadverse effects |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aSarcoma, Ewing _xdrug therapy |
| 650 | 0 | 4 |
_aTopotecan _xadministration & dosage |
| 700 | 1 | _aDevidas, Meenakshi | |
| 700 | 1 | _aLafreniere, Dominique | |
| 700 | 1 | _aSouid, Abdul-Kader | |
| 700 | 1 | _aMeyers, Paul A | |
| 700 | 1 | _aGebhardt, Mark | |
| 700 | 1 | _aStine, Kimo | |
| 700 | 1 | _aNicholas, Richard | |
| 700 | 1 | _aPerlman, Elizabeth J | |
| 700 | 1 | _aDubowy, Ronald | |
| 700 | 1 | _aWainer, Irving W | |
| 700 | 1 | _aDickman, Paul S | |
| 700 | 1 | _aLink, Michael P | |
| 700 | 1 | _aGoorin, Allen | |
| 700 | 1 | _aGrier, Holcombe E | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 24 _gno. 1 _gp. 152-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2005.02.1717 _zAvailable from publisher's website |
| 999 |
_c16000451 _d16000451 |
||